RECOMBIVAX HB 5 ug/.5mL
Hepatitis B Vaccine (Recombinant) · INJECTION, SUSPENSION · Merck Sharp & Dohme LLC
No Recall History
Plain English
RECOMBIVAX HB is a injection, suspension containing hepatitis b vaccine (recombinant) at 5 ug/.5mL, taken intramuscular. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- RECOMBIVAX HB
- Generic Name
- Hepatitis B Vaccine (Recombinant)
- NDC Code (Product)
0006-4093- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 5 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA101066
- Marketing Start
- 07/23/1986
Recall History
No Recall HistoryFrequently Asked Questions
What is RECOMBIVAX HB used for?
RECOMBIVAX HB contains Hepatitis B Vaccine (Recombinant). It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is RECOMBIVAX HB a controlled substance?
RECOMBIVAX HB is not classified as a controlled substance by the DEA.
What is the generic name for RECOMBIVAX HB?
The generic name for RECOMBIVAX HB is Hepatitis B Vaccine (Recombinant). There are 5 other brand versions of Hepatitis B Vaccine (Recombinant).
What is the NDC code for RECOMBIVAX HB 5 ug/.5mL?
The NDC (National Drug Code) for RECOMBIVAX HB 5 ug/.5mL is 0006-4093, listed by Merck Sharp & Dohme LLC.